focus -WSS

focus

author：Wikipedia 2025-09-28 23:47:12 - browse：6

Illustration of a red human heart with an EKG line in the middle. -- health coverage from STAT — Adobe

Just weeks after Novo Nordisk announced that its obesity drug Wegovy cut the risk of heart complications in a major trial, the company now has results from a different study showing the treatment can also benefit people with a common type of heart failure.

The results, published Friday in the New England Journal of Medicine, found that among people with obesity and heart failure with preserved ejection fraction, or HFpEF, those taking Wegovy experienced greater improvements in symptoms and physical function compared with those on placebo. The improvements were greater than what’s been seen in trials of some other HFpEF treatments.

Novo previously shared topline results in investor calls, but the new study contains the full findings, which are also being presented at the European Society of Cardiology conference this week.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Women's World Cup brings attention to abuse in soccer

WSS

Dario to buy mental health app maker Twill in cash and stock deal

China sends large group of warplanes, navy ships towards Taiwan in forceful display

One Duchenne patient's bittersweet hope for new treatment

NIH study of ME/CFS points to clear biological hallmarks

Antivenom research: Lessons from HIV applied in search for universal antidote

Dario to buy mental health app maker Twill in cash and stock deal

leisure time

focus

hotspot

New air purifier tech could be key to improving indoor air quality

Community Health Systems hospitals under DOJ investigation

Cancer drug shortages should be causing more outrage

Dario to buy mental health app maker Twill in cash and stock deal

Hepatitis C has a cure — but many Americans still lack access to it

China sends large group of warplanes, navy ships towards Taiwan in forceful display

After affirmative action ruling, medical educators look to 'holistic review'

PBM reform efforts get punted in Congress

Cancer drug shortages should be causing more outrage

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

hotspot

He's a Nobel laureate. Critics say he was misleading on Covid

Britney Spears to release memoir, 'The Woman In Me,' later this year

Dario to buy mental health app maker Twill in cash and stock deal

A solution to the after

Alabama hospital puts IVF treatments on hold

A new nitrogen execution bill also undermines medical licensing

hotspot

hotspot

Wikipedia

hotspot